Shan Li et al.
COMMUNICATIONS
References
Organofluorine Compounds: Chemistry and Applica-
tions; Springer-Verlag: Berlin, 2000, p 137.
[8] a) G. Himbert, W. Schwickerath, Liebigs Ann. Chem.
1984, 85–97; b) M. D. Hill, M. Movassaghi, J. Am.
Chem. Soc. 2006, 128, 4592–4593; c) M. D. Hill, M.
Movassaghi, Synthesis 2007, 7, 1115–1119; d) Y. M.
Wu, Y. Li, J. Deng, Tetrahedron Lett. 2005, 46, 5357–
5360.
[9] a) P. R. Likhar, M. S. Subhas, S. Roy, M. L Kantam,
Org. Biomol. Chem. 2009, 7, 85–93; b) V. Singg, S.
Madapa, P. R. Maulik, S. Batra, Synthesis 2006, 12,
1995–2004; c) P. Evans, P. Hogg, J. Hinsley, S. Korn, J.
E . Muir, Tetrahedron 2005, 61, 9696–9704; d) D. M.
Volochnyuk, D. G. Krotko, S. A. Kovalyova, A. A. Tol-
machev, Synthesis 2003, 1531–1540.
[10] a) C. S. Joseph, J. Phys. Org. Chem. 2009, 22, 110–117;
b) A. Isobe, J. Takagi, T. Katagiri, K. Uneyama, Org.
Lett. 2008, 10, 2657–2659; c) H. Yanai, K. Kawada, T.
Taguchi, Tetrahedron 2007, 63, 2153–2160; d) S. El
Kharrat, A. Dahmani, P. Laurent, H. Blancou, J. Org.
Chem. 2005, 70, 8327–8331; e) I. L. Baraznenok, V. G.
Nenajdenko, E. S. Balenkova, Eur. J. Org. Chem. 1999,
4, 937–941; f) H. Keller, M. Schlosser, Tetrahedron
1996, 52, 4637–4644.
[1] a) A. Shirai, O. Miyata, D. J. Procter, T. Naito, J. Org.
Chem. 2008, 73, 4464–4475; b) T. Shigeyama, K. Kata-
kama, M. Kitajima, H. Takayama, Org. Lett. 2007, 9,
4069–4072; c) D. Keck, S. Vanderheiden, S. Braese,
Eur. J. Org. Chem. 2006, 21, 4916–4923; d) M. Alvarez,
M. A. Bros, G. Gras, J. Joule, Eur. J. Org. Chem. 1999,
5, 1173–1183; e) L. A. Mitscher, T. Suzuki, G. Clark,
M. S. Bathala, Heterocycles 1976, 5, 565–604; f) X.-F.
Lin, Y. Li, D.-W. Ma, Chin. J. Chem. 2004, 22, 932–934.
[2] a) M. Abass, Heterocycles 2005, 65, 901–905; b) G. D.
Hennry, Tetrahedron 2004, 60, 6043–6061; c) G. Jones,
in: Comprehensive Heterocyclic Chemistry, Vol. 2,
(Eds.: A. R. Katritzky, A. R. Rees), Pergamon, New
York, 1984, p 395.
[3] a) H. Moskowitz, J. Mayrargue, E. Prina, Chem.
Pharm. Bull. 2001, 49, 480–483; b) A. R. Patel, R. E.
Lutz, J. Med. Chem. 1971, 14, 926–928.
[4] a) H. Kitajima, Y. Tanakaa, Patent WO 2003024942,
2003; b) R. Kuang, N. Y. Shih, J. Cao, Patent WO
2005116009, 2005; c) J. G. Montant, Patent WO
2000026208, 2000.
[5] a) L. Strekowski, H. Lee, J. Fluorine Chem. 2000, 104,
281; b) H. Kagoshima, T. Akiyama, Org. Lett. 2000, 2,
1577; c) B. Crousse, D. Bonnet-Delpon, J. Org. Chem.
2000, 65, 5009; d) M. Schlosser, H. Keller, J. Yang, Tet-
rahedron Lett. 1997, 38, 8523; e) H. Lee, J. C. Mason,
Tetrahedron 1998, 54, 7947; f) T. Fuchigami, S. Ichika-
wa, J. Org. Chem. 1994, 59, 607.
[6] a) I. Ojima, J. R. McCarthy, J. T. Welch, Biomedical
Frontiers of Fluorine Chemistry, ACS Symposium
Series, no. 639, Washington, 1996; b) M. Hudlicky,
Chemistry of Organic Fluorine Compounds, Ellis Hor-
wood Ltd, Chichester, 1992.
[11] a) H. Amii, Y. Kishikawa, K. Uneyama, Org. Lett.
2001, 3, 1109–1112.
[12] a) H. Mizukami, K. Maeda, H. Watanabe, K. Uneyama,
J. Org. Chem. 1993, 58, 32–35; b) K. Uneyama, H. Wa-
tanabe, Tetrahedron Lett. 1991, 32, 1495–1498.
[13] Our work demonstrated that, with K3PO4 as the base,
fluorinated imidoyl iodides can react with terminal al-
kynes catalyzed by CuI in CH3CN at 508C to afford
the alkynylimine with good to excellent yields (in prep-
aration), which is detailed in the Supporting Informa-
tion.
[14] a) A. W. Sromek, A. L. Rheingold, D. J. Wink, V. Ge-
vorgyon, Synlett 2006, 2325–2328; b) A. V. Kel’in,
A. W. Sromek, V. Gevorgyon, J. Am. Chem. Soc. 2001,
123, 2074–2075.
[7] a) R. Filler, Y. Kobayashi, in: Organofluorine Com-
pounds in Medicinal Chemistry and Biomedical Appli-
cations, Elsevier, New York, 1993, p 1; b) T. Hiyama,
1586
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 1582 – 1586